Recommendations about Coronavirus for our patients
March 6, 2020
To our Multiple Sclerosis patients, their families and caregivers.The Coronavirus/COVID-19 outbreak is rapidly evolving, has entered the United States and willcertainly escalate before it subsides. The best up to date information can be obtained from theCenters for Disease Control at: https://www.cdc.gov/coronavirus/2019-ncov/about/index.htmlThe information in this posting is based on our best understanding of COVID-19 as of 3/4/2020.It is important to recognize that people with MS who are on...
Immune Disease Activity in MS may differ according to Ethnicity
January 15, 2020
People with MS self-identifying with the Black African diaspora, and/or with Latin American ethnicity are on average more likely to experience a severe MS disease course. This trend is supported by several independent studies conducted over the past two decades. Collectively, these studies show that clinical disability and MRI measures; including, lesion number, lesion volume, and tissue atrophy, tend to be significantly pronounced among study participants with MS self-reporting as African...
Decreasing risk of cognitive decline
May 6, 2019
Cognitive changes occur in patients with multiple sclerosis. They also occur in all of us as we age. Aging results in some neuronal loss but patients with prior brain insults from neurodegenerative diseases lose neurons at a faster rate especially in certain brain regions.Patients ask about medications to prevent and treat cognitive decline. All the recent news reiterated that we still do not have great treatments for alzheimer’s or understand what causes it.We know we need to prevent brain...
